Evidence map›Paper›PMID 39089815›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Medhat M Osman, Amir Iravani, Catherine Mitchell, Rodney J Hicks, Elisa Perry, Michael S Hofman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Medhat M OsmanDepartment of Radiology, Saint Louis University Hospital, St. Louis, Missouri; medhat.osman@health.slu.edu.
Amir IravaniDepartment of Radiology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington.
Catherine MitchellDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Rodney J HicksMelbourne Theranostic Innovation Centre, Melbourne, Victoria, Australia.
Elisa PerryDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and.
Michael S HofmanDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the incidence and potential etiology of tracheobronchial uptake in patients being evaluated by

Indexed as

BronchiGlutamate Carboxypeptidase IILysinePositron Emission Tomography Computed TomographyProstatic NeoplasmsTracheaUreaAgedAged, 80 and overAntigens, SurfaceBiological TransportHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective Studies2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acidAntigens, SurfaceFOLH1 protein, humanGlutamate Carboxypeptidase IILysineRadiopharmaceuticalsUrea18F-DCFPyLPET/CTprostate cancersubmucosal glandstrachea

Identifiers

PMID39089815
PMCPMC11372262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.